Hold the vial up to a light
New formulations and variants of peptides are constantly emerging, and the law has to react and respond. The Poisons List under Section 8 of the Poisons and Therapeutic Goods Act (NSW) adopts the Poisons Standard, which lists medicines and chemicals into Schedules depending on their risk, use, requirements and restrictions
Accelerated approval for Filspari was granted based on data from the Phase III PROTECT study, which showed that the small molecule blocker lowered urine protein levels more than three times as much as the active control, Avapro
TFR: transferrin receptor
All compounds and substances distributed by Loti Labs are designated as research chemicals for laboratory use only
Cagrilintide vs semaglutide (Wegovy/Ozempic) Mechanism: Cagrilintide: Amylin receptor agonist Semaglutide: GLP-1 receptor agonist Different pathways Weight loss: Cagrilintide alone: 10-12% Semaglutide alone: 10-15% Similar efficacy monotherapy Gastric emptying: Cagrilintide: Very strong delay Semaglutide: Moderate delay Cagrilintide more powerful Side effects: Cagrilintide: More GI effects (stronger gastric slowing) Semaglutide: Moderate GI effects Cagrilintide harder to tolerate for some Availability: Cagrilintide: Investigational (not approved) Semaglutide: FDA approved, widely available Semaglutide easier to obtain currently Combination potential: Synergistic together (CagriSema) 15-25% weight loss combined Best of both mechanisms Verdict: Similar monotherapy efficacy, but combine for maximum results
